Depakote

Migraine, Acute Coryza, Behcet Syndrome + 4 more
Treatment
20 Active Studies for Depakote

What is Depakote

Valproic acidThe Generic name of this drug
Treatment SummaryValproic acid, also known as valproate, is an anticonvulsant drug first synthesized in 1881. It was discovered in 1963 to have anti-seizure properties, and was approved by the FDA in 1978 under the brand name Depakene. Valproic acid is now used to treat a variety of conditions, such as neuroprotection, bipolar disorder, migraine headaches, and cancer. It is also being studied for its anti-proliferative effects in many clinical trials.
Depakeneis the brand name
image of different drug pills on a surface
Depakote Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Depakene
Valproic acid
1978
481

Effectiveness

How Depakote Affects PatientsValproate helps reduce the frequency of seizures, migraines, and bipolar mania symptoms. It is believed to work by increasing the amount of inhibition in the brain, as well as protecting neurons from damage. Although the exact cause is unknown, taking valproate can be toxic to the liver and harmful to unborn babies. There is also evidence that it can reactivate HIV when taken with HAART drugs, although a larger study did not show a significant effect on HIV reservoirs.
How Depakote works in the bodyValproate works in multiple ways to reduce seizures, treat migraines, and manage bipolar disorder. It increases the amount of a neurotransmitter called GABA, which reduces nerve firing. Valproate also blocks certain enzymes involved in fatty acid metabolism and decreases the production of compounds that cause inflammation, which may help with migraines. Valproate also acts as an inhibitor of histone deacetylase, which helps to decrease the activity of certain genes. All of these effects work together to reduce symptoms and treat disorder.

When to interrupt dosage

The proposed dose of Depakote is contingent upon the identified condition, such as Seizures, Seizure, Absence and Complex Partial Seizures. The extent of dosage is contingent upon the delivery technique (e.g. Injection, solution - Intravenous or Capsule, delayed release) featured in the table beneath.
Condition
Dosage
Administration
Mental Depression
, 250.0 mg, 125.0 mg, 500.0 mg, 250.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 500.0 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, Capsule - Oral, Solution, Solution - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, delayed release particles, Tablet, delayed release particles - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule, coated pellets, Capsule, coated pellets - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Injection, Injection - Intravenous, Syrup, Syrup - Oral, Liquid, Liquid - Intravenous, Capsule, Delayed Release - Oral, Capsule, Delayed Release
Seizures
, 250.0 mg, 125.0 mg, 500.0 mg, 250.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 500.0 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, Capsule - Oral, Solution, Solution - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, delayed release particles, Tablet, delayed release particles - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule, coated pellets, Capsule, coated pellets - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Injection, Injection - Intravenous, Syrup, Syrup - Oral, Liquid, Liquid - Intravenous, Capsule, Delayed Release - Oral, Capsule, Delayed Release
Migraine
, 250.0 mg, 125.0 mg, 500.0 mg, 250.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 500.0 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, Capsule - Oral, Solution, Solution - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, delayed release particles, Tablet, delayed release particles - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule, coated pellets, Capsule, coated pellets - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Injection, Injection - Intravenous, Syrup, Syrup - Oral, Liquid, Liquid - Intravenous, Capsule, Delayed Release - Oral, Capsule, Delayed Release
Acute Coryza
, 250.0 mg, 125.0 mg, 500.0 mg, 250.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 500.0 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, Capsule - Oral, Solution, Solution - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, delayed release particles, Tablet, delayed release particles - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule, coated pellets, Capsule, coated pellets - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Injection, Injection - Intravenous, Syrup, Syrup - Oral, Liquid, Liquid - Intravenous, Capsule, Delayed Release - Oral, Capsule, Delayed Release
Behcet Syndrome
, 250.0 mg, 125.0 mg, 500.0 mg, 250.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 500.0 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, Capsule - Oral, Solution, Solution - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, delayed release particles, Tablet, delayed release particles - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule, coated pellets, Capsule, coated pellets - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Injection, Injection - Intravenous, Syrup, Syrup - Oral, Liquid, Liquid - Intravenous, Capsule, Delayed Release - Oral, Capsule, Delayed Release
Epilepsy
, 250.0 mg, 125.0 mg, 500.0 mg, 250.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 500.0 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, Capsule - Oral, Solution, Solution - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, delayed release particles, Tablet, delayed release particles - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule, coated pellets, Capsule, coated pellets - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Injection, Injection - Intravenous, Syrup, Syrup - Oral, Liquid, Liquid - Intravenous, Capsule, Delayed Release - Oral, Capsule, Delayed Release
Seizures
, 250.0 mg, 125.0 mg, 500.0 mg, 250.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 500.0 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, Capsule - Oral, Solution, Solution - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, delayed release particles, Tablet, delayed release particles - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Capsule, coated pellets, Capsule, coated pellets - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Injection, Injection - Intravenous, Syrup, Syrup - Oral, Liquid, Liquid - Intravenous, Capsule, Delayed Release - Oral, Capsule, Delayed Release

Warnings

Depakote Contraindications
Condition
Risk Level
Notes
Mitochondrial Diseases
Do Not Combine
Liver Failure
Do Not Combine
Disease
Do Not Combine
Liver Diseases
Do Not Combine
Enzymes
Do Not Combine
There are 20 known major drug interactions with Depakote.
Common Depakote Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Valproic acid.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Valproic acid.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Valproic acid.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Valproic acid.
Amiodarone
Major
The metabolism of Amiodarone can be decreased when combined with Valproic acid.
Depakote Toxicity & Overdose RiskThe toxic dose of Valproate in mice is 1098mg/kg and in rats is 670mg/kg. Overdosing on Valproate may cause sleepiness, heart block, deep coma, and high sodium levels. There have been reports of fatalities, but some people have recovered from Valproate levels as high as 2120 mcg/mL. Dialysis can be used to remove the unbound fraction of the drug. Pregnant women taking Valproate have a higher risk of their child having neural tube defects or other serious structural abnormalities. Valproate has also been linked to an increased
image of a doctor in a lab doing drug, clinical research

Depakote Novel Uses: Which Conditions Have a Clinical Trial Featuring Depakote?

65 active trials are currently underway to appraise the potential of Depakote to address Migraine, Complex Partial Seizures and Acute Coryza.
Condition
Clinical Trials
Trial Phases
Migraine
54 Actively Recruiting
Phase 4, Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1
Seizures
0 Actively Recruiting
Seizures
0 Actively Recruiting
Acute Coryza
1 Actively Recruiting
Not Applicable
Behcet Syndrome
1 Actively Recruiting
Not Applicable
Epilepsy
0 Actively Recruiting
Mental Depression
1 Actively Recruiting
Not Applicable

Depakote Reviews: What are patients saying about Depakote?

5Patient Review
5/14/2017
Depakote for Bipolar Disorder in Remission
I've been using this treatment for 18 years with minimal side effects and it has really worked well for me.
5Patient Review
9/25/2022
Depakote for Bipolar Disorder in Remission
This drug has been a game-changer for me. Since taking it, I wake up every day feeling excited and happy. My anxiety is practically nonexistent now.
5Patient Review
5/15/2017
Depakote for Bipolar Depression
Over the last couple years, I've tried a lot of different drugs and depakote is the only one that's helped me stay stable.
4.7Patient Review
1/17/2017
Depakote for Bipolar Depression
I've been on Depakote for over 25 years and it's really effective. However, I have to take lactulose twice a week because the medication raises my ammonia levels. This is not fun. If anyone has suggestions about how to reduce my ammonia levels, please let me know!
4.3Patient Review
11/28/2020
Depakote for Bipolar Depression
One of the longest working medications for me. Slight hair loss. 750mg per day with 40mg paroxetine.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about depakote

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Depakote an antipsychotic?

"Side effects of Depakote and Abilify that are similar include drowsiness, weakness, nausea, vomiting, stomach upset, constipation, weight changes, or vision changes/blurred vision."

Answered by AI

What is Depakote drug used for?

"Depakote was first prescribed in 19831. It is an antiepileptic drug (AED) and is used to treat complex partial seizures, simple and complex absence seizures, as well as acute manic symptoms in patients with bipolar disorder."

Answered by AI

What are side effects of Depakote?

"B: Depakote may cause drowsiness, nausea, abdominal pain, diarrhea, vomiting, low platelet count, tremors, tiredness, and hair loss. These side effects may be mild to moderate, but they could also be indicative of a more serious condition."

Answered by AI

Is Depakote an antipsychotic or mood stabilizer?

"Valproate works in the brain to stabilize mood swings associated with bipolar disorder, seizures, and migraines."

Answered by AI

Clinical Trials for Depakote

Have you considered Depakote clinical trials? We made a collection of clinical trials featuring Depakote, we think they might fit your search criteria.
Have you considered Depakote clinical trials? We made a collection of clinical trials featuring Depakote, we think they might fit your search criteria.
Have you considered Depakote clinical trials? We made a collection of clinical trials featuring Depakote, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top